Positron Emission Tomography Imaging in Vasculitis.

[1]  P. Nienhuis,et al.  Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica , 2022, Frontiers in Medicine.

[2]  Hua-Ching Chang,et al.  Risk of ischaemic heart diseases and stroke in behçet disease: A systematic review and meta‐analysis , 2022, European journal of clinical investigation.

[3]  P. Demelo-Rodríguez,et al.  Arterial and venous involvement in Behçet’s syndrome: a narrative review , 2022, Journal of Thrombosis and Thrombolysis.

[4]  I. Aksentijevich,et al.  Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2) , 2022, Seminars in Immunopathology.

[5]  He-bei Li,et al.  Imaging features of 18F-FDG PET/CT in different types of systemic vasculitis , 2022, Clinical Rheumatology.

[6]  D. Pucar,et al.  FDG PET vascular imaging in IgG4-RD: Potential and challenges , 2021, Journal of Nuclear Cardiology.

[7]  D. Burgner,et al.  FDG-PET imaging in a child with Kawasaki disease: systemic and coronary artery inflammation without dilatation , 2021, Archives of Disease in Childhood.

[8]  J. Burns,et al.  Global epidemiology of vasculitis , 2021, Nature Reviews Rheumatology.

[9]  Yoo Jin Lee,et al.  ACR Appropriateness Criteria® Noncerebral Vasculitis. , 2021, Journal of the American College of Radiology : JACR.

[10]  Y. Fukumoto,et al.  Vascular/perivascular inflammation in IgG4-related disease , 2021, Journal of Nuclear Cardiology.

[11]  I. Matsumura,et al.  FDG-PET/CT and Auricular Cartilage Biopsy Are Useful for Diagnosing with Relapsing Polychondritis in Patients without Auricular Symptoms , 2021, Life.

[12]  T. Quéméneur,et al.  FDG/PET-CT findings in a first series of 10 patients with polyarteritis nodosa. , 2021, Rheumatology.

[13]  A. Handique,et al.  Magnetic Resonance Angiography and Multidetector CT Angiography in the Diagnosis of Takayasu's Arteritis: Assessment of Disease Extent and Correlation with Disease Activity. , 2021, Current medical imaging.

[14]  A. Lammertsma,et al.  Long axial field of view PET scanners: a road map to implementation and new possibilities , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  R. Slart,et al.  Comparison and validation of FDG-PET/CT scores for polymyalgia rheumatica , 2021, Rheumatology.

[16]  P. Heeringa,et al.  A Distinct Macrophage Subset Mediating Tissue Destruction and Neovascularization in Giant Cell Arteritis: Implication of the YKL‐40/Interleukin‐13 Receptor α2 Axis , 2021, Arthritis & rheumatology.

[17]  P. Zanotti-Fregonara,et al.  In vitro and pilot in vivo imaging of 18 kDa translocator protein (TSPO) in inflammatory vascular disease , 2021, EJNMMI Research.

[18]  F. Jamar,et al.  Diagnostic value of [18F]FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[19]  R. Slart,et al.  Therapy response evaluation in large vessel vasculitis: a new role for [18F]FDG-PET/CT? , 2021, Rheumatology.

[20]  M. Uder,et al.  Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study. , 2021, Rheumatology.

[21]  A. Afshar-Oromieh,et al.  Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT , 2021, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  P. Nienhuis,et al.  A Review on the Value of Imaging in Differentiating between Large Vessel Vasculitis and Atherosclerosis , 2021, Journal of personalized medicine.

[23]  C. Crowson,et al.  Prevalence of Takayasu Arteritis: A Population-based Study , 2021, The Journal of Rheumatology.

[24]  P. Cacoub,et al.  Medium- and Large-Vessel Vasculitis. , 2021, Circulation.

[25]  S. Selvaraj,et al.  Potential Cardiovascular Applications of Total-body PET Imaging. , 2021, PET clinics.

[26]  Wen Zhang,et al.  Fibroblast Activation Protein–Targeted PET/CT with 68Ga-FAPI for Imaging IgG4-Related Disease: Comparison to 18F-FDG PET/CT , 2020, The Journal of Nuclear Medicine.

[27]  A. Tomelleri,et al.  Ultrasonographic Halo Score in giant cell arteritis: association with intimal hyperplasia and ischaemic sight loss , 2020, Rheumatology.

[28]  R. Tothill,et al.  FAPI PET/CT: Will It End the Hegemony of 18F-FDG in Oncology? , 2020, The Journal of Nuclear Medicine.

[29]  W. Schmidt,et al.  Imaging for Diagnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides , 2020, Current Rheumatology Reports.

[30]  P. Heeringa,et al.  Distinct macrophage phenotypes skewed by local granulocyte macrophage colony‐stimulating factor (GM‐CSF) and macrophage colony‐stimulating factor (M‐CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritis , 2020, Clinical & translational immunology.

[31]  S. Mackie,et al.  Diagnostic Accuracy of Symptoms, Physical Signs, and Laboratory Tests for Giant Cell Arteritis , 2020, JAMA internal medicine.

[32]  J. Stone,et al.  Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging , 2020, Annals of the Rheumatic Diseases.

[33]  P. Nienhuis,et al.  Visual and semiquantitative assessment of cranial artery inflammation with FDG-PET/CT in giant cell arteritis. , 2020, Seminars in arthritis and rheumatism.

[34]  T. Fryer,et al.  Novel Approach to Imaging Active Takayasu Arteritis Using Somatostatin Receptor Positron Emission Tomography/Magnetic Resonance Imaging. , 2020, Circulation. Cardiovascular imaging.

[35]  R. Luqmani,et al.  Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia , 2020, Annals of the rheumatic diseases.

[36]  H. Zachrisson,et al.  Vascular ultrasound for monitoring of inflammatory activity in Takayasu arteritis , 2020, Clinical physiology and functional imaging.

[37]  Yining Wang,et al.  The Clinical Features, Risk Factors, and Outcome of Aneurysmal Lesions in Behcet's Disease , 2019, Journal of immunology research.

[38]  J. Alqanatish,et al.  Relapsing polychondritis in children: A review , 2019, Modern rheumatology.

[39]  A. Tomelleri,et al.  Large-vessel Vasculitis Affecting the Aorta and its Branches in Relapsing Polychondritis: Case Series and Systematic Review of the Literature , 2019, Journal of Rheumatology.

[40]  G. Hatemi,et al.  Aortic involvement in relapsing polychondritis: case-based review , 2019, Rheumatology International.

[41]  L. Barra,et al.  Characteristics of Takayasu Arteritis Patients with Severe Ischemic Events , 2019, The Journal of Rheumatology.

[42]  P. Merkel,et al.  Derivation of an angiographically based classification system in Takayasu's arteritis: an observational study from India and North America. , 2019, Rheumatology.

[43]  A. Boots,et al.  Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica , 2019, Front. Immunol..

[44]  Xiao-juan Guo,et al.  Multiple cardiovascular involvements in Behçet’s disease: unique utility of 18F-FDG PET/CT in diagnosis and follow-up , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[45]  J. Roscamp,et al.  Relapsing polychondritis: a clinical review for rheumatologists. , 2018, Rheumatology.

[46]  J. Ejlersen,et al.  Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[47]  A. Iagnocco,et al.  Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group , 2018, RMD Open.

[48]  L. Gormsen,et al.  Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[49]  R. Boellaard,et al.  FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[50]  D. Bluemke,et al.  F-Fluorodeoxyglucose–Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis , 2018 .

[51]  A. Tomelleri,et al.  Prevalence of Takayasu arteritis in young women with acute ischemic heart disease. , 2018, International journal of cardiology.

[52]  A. Iagnocco,et al.  EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice , 2018, Annals of the rheumatic diseases.

[53]  L. Barra,et al.  Ischemic complications in Takayasu's arteritis: A meta-analysis. , 2017, Seminars in arthritis and rheumatism.

[54]  J. Stone,et al.  Clinically isolated aortitis: pitfalls, progress, and possibilities. , 2017, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[55]  B. McCrindle,et al.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.

[56]  H. Shirato,et al.  Characteristics of immunoglobulin G4-related aortitis/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography/computed tomography co-registered with contrast-enhanced computed tomography , 2017, EJNMMI Research.

[57]  G. Ioannidis,et al.  High‐Resolution Magnetic Resonance Imaging of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Cohort Study , 2017, Arthritis & rheumatology.

[58]  G. V. van Dongen,et al.  B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients , 2016, Arthritis Research & Therapy.

[59]  Andrea Barbetta,et al.  Updates in Pathophysiology, Diagnosis and Management of Takayasu Arteritis. , 2016, Annals of vascular surgery.

[60]  Tamás Vicsek,et al.  A nationwide study of the epidemiology of relapsing polychondritis , 2016, Clinical epidemiology.

[61]  D. Misra,et al.  Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk , 2016, Rheumatology International.

[62]  Y. H. Lee,et al.  Diagnostic accuracy of 18F-FDG PET or PET/CT for large vessel vasculitis , 2016, Zeitschrift für Rheumatologie.

[63]  M. Gulliford,et al.  Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study. , 2015, Rheumatology.

[64]  A. Angelini,et al.  Consensus statement on surgical pathology of the aorta from the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology: I. Inflammatory diseases. , 2015, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[65]  J. O'dell,et al.  The Role of 18F Fluorodeoxyglucose Positron Emission Tomography Scanning in the Diagnosis and Management of Systemic Vasculitis , 2015, International journal of rheumatic diseases.

[66]  O. Yamada,et al.  Characteristics and Fate of Systemic Artery Aneurysm after Kawasaki Disease. , 2015, Jornal de Pediatria.

[67]  O. Tufekcioglu,et al.  Intracardiac thrombus in Behçet’s disease: four new cases and a comprehensive literature review , 2015, Rheumatology International.

[68]  N. Sut,et al.  Vascular involvement in Behçet's syndrome: a retrospective analysis of associations and the time course. , 2014, Rheumatology.

[69]  M. Waltham,et al.  18F-FDG PET-CT uptake is a feature of both normal diameter and aneurysmal aortic wall and is not related to aneurysm size , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[70]  Hua Chen,et al.  Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[71]  S. Unizony,et al.  The heart in vasculitis. , 2014, Rheumatic diseases clinics of North America.

[72]  M. Alba,et al.  Diagnosis and classification of polyarteritis nodosa. , 2014, Journal of autoimmunity.

[73]  P. Ganz,et al.  Depletion of B‐Cells With Rituximab Improves Endothelial Function and Reduces Inflammation Among Individuals With Rheumatoid Arthritis , 2012, Journal of the American Heart Association.

[74]  A. D. de Souza,et al.  Diagnostic and classification criteria of Takayasu arteritis. , 2014, Journal of autoimmunity.

[75]  Y. Weerakkody.  Aortitis , 2013, Radiopaedia.org.

[76]  M. Boniuk,et al.  IgG4 related cardiac disease. , 2013, Methodist DeBakey cardiovascular journal.

[77]  P. Christian,et al.  EANM/SNMMI Guideline for 18F-FDG Use in Inflammation and Infection* , 2013, The Journal of Nuclear Medicine.

[78]  J. C. Cohen Tervaert,et al.  Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides , 2013 .

[79]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[80]  G. Treglia,et al.  Usefulness of 18F-FDG PET/CT in Evaluating Disease Activity at Different Times in a Patient With Chronic Periaortitis , 2013, Nuclear Medicine and Molecular Imaging.

[81]  J. Stone,et al.  IgG4-related disease. , 2012, The New England journal of medicine.

[82]  P. Cluzel,et al.  Long-Term Outcome of Arterial Lesions in Behçet Disease: A Series of 101 Patients , 2012, Medicine.

[83]  Roger N Gunn,et al.  An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[84]  D. Mozaffarian,et al.  Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. , 2011, The American journal of cardiology.

[85]  John O. Prior,et al.  Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[86]  Sung Bin Cho,et al.  Detection of cardiovascular system involvement in Behçet's disease using fluorodeoxyglucose positron emission tomography. , 2011, Seminars in arthritis and rheumatism.

[87]  Oliver Gaemperli,et al.  Detection and Quantification of Large-Vessel Inflammation with 11C-(R)-PK11195 PET/CT , 2011, The Journal of Nuclear Medicine.

[88]  Robert B. Innis,et al.  Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands , 2011, The Journal of Nuclear Medicine.

[89]  A. Davies,et al.  Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography. , 2010, Journal of the American College of Cardiology.

[90]  R. Holman,et al.  Hospitalizations for Kawasaki Syndrome Among Children in the United States, 1997–2007 , 2010, The Pediatric infectious disease journal.

[91]  E. C. Han,et al.  Comparison of the clinical features of recurrent aphthous stomatitis and Behçet’s disease , 2009, Clinical and experimental dermatology.

[92]  T. Bley,et al.  Imaging for large-vessel vasculitis , 2009, Current opinion in rheumatology.

[93]  Y. Choi,et al.  Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. , 2007, Journal of vascular surgery.

[94]  S. Mori,et al.  Isolated necrotizing arteritis (localized polyarteritis nodosa): examination of the histological process and disease entity based on the histological classification of stage and histological differences from polyarteritis nodosa. , 2007, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[95]  E. Lee,et al.  Clinical Features of Polyarteritis Nodosa in Korea , 2006, Journal of Korean medical science.

[96]  E. Matteson,et al.  Cogan syndrome: a retrospective review of 60 patients throughout a half century. , 2006, Mayo Clinic proceedings.

[97]  İ. Tuğal-Tutkun,et al.  Uveitis in Behçet disease: an analysis of 880 patients. , 2004, American journal of ophthalmology.

[98]  J. Pouchot,et al.  Typical and atypical Cogan's syndrome: 32 cases and review of the literature. , 2004, Rheumatology.

[99]  C. Cooper,et al.  Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study , 2004, Heart.

[100]  W. Oyen,et al.  F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. , 2003, The Netherlands journal of medicine.

[101]  M. Gompels,et al.  Takayasu arteritis: a review. , 2002, Journal of clinical pathology.

[102]  D. Scott,et al.  Epidemiology of vasculitis in Europe , 2001, Annals of the rheumatic diseases.

[103]  N. Tamaki,et al.  FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[104]  D. V. van Thiel,et al.  Gastrointestinal manifestations of Behcet's disease. , 2000, Journal of clinical gastroenterology.

[105]  C. Trépo,et al.  Polyarteritis Nodosa Related to Hepatitis B Virus A Prospective Study with Long‐Term Observation of 41 Patients , 1995, Medicine.

[106]  T Ido,et al.  High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[107]  J. Foidart,et al.  Antibodies to type II collagen in relapsing polychondritis. , 1978, The New England journal of medicine.

[108]  G. Hatemi,et al.  Behçet syndrome , 2021, Nature Reviews Disease Primers.